TM4SF4 Inhibitors
The tetraspanin family, which includes TM4SF4, is characterized by proteins that span the membrane four times and are involved in complex network formation with other proteins, influencing various cellular processes. They are not enzymes with active sites for traditional inhibition but rather facilitate cell signaling and interaction. Their inhibition, in the conventional sense, is not applicable. Instead, one might influence the function of TM4SF4 indirectly by altering the composition of the cellular membrane or disrupting the signaling pathways they are involved in.
The chemical class that might be considered as indirect TM4SF4 inhibitors would, therefore, include compounds that affect the structure and integrity of lipid rafts, signaling pathways, protein prenylation and palmitoylation, and other post-translational modifications that affect protein-protein interactions within the cell membrane. These compounds could potentially influence the function of TM4SF4 by disrupting the microdomains that are necessary for its activity or by altering the signaling cascades in which TM4SF4 is involved. However, it is important to note that the effects of such compounds would likely lack specificity for TM4SF4 and would also impact a wide range of cellular processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
GW4869 | 6823-69-4 | sc-218578 sc-218578A | 5 mg 25 mg | $203.00 $611.00 | 24 | |
A neutral sphingomyelinase inhibitor that could affect lipid raft composition and thereby potentially alter the function of tetraspanin-enriched microdomains where TM4SF4 may reside. | ||||||
Methyl-β-cyclodextrin | 128446-36-6 | sc-215379A sc-215379 sc-215379C sc-215379B | 100 mg 1 g 10 g 5 g | $20.00 $48.00 $160.00 $82.00 | 19 | |
A cholesterol-depleting agent that disrupts lipid rafts, potentially affecting the localization and function of tetraspanins like TM4SF4. | ||||||
Manumycin A | 52665-74-4 | sc-200857 sc-200857A | 1 mg 5 mg | $219.00 $634.00 | 5 | |
A farnesyltransferase inhibitor that may alter the prenylation and membrane association of signaling proteins, potentially influencing TM4SF4-related signaling. | ||||||
2-Bromohexadecanoic acid | 18263-25-7 | sc-251714 sc-251714A | 10 g 50 g | $53.00 $201.00 | 4 | |
An inhibitor of protein palmitoylation that could disrupt the anchoring of proteins in membranes, potentially affecting interactions with TM4SF4. | ||||||
D609 | 83373-60-8 | sc-201403 sc-201403A | 5 mg 25 mg | $189.00 $575.00 | 7 | |
A phosphatidylcholine-specific phospholipase C inhibitor that may alter lipid signaling pathways, potentially influencing TM4SF4-related processes. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
An ionophore that disrupts intracellular trafficking and could affect the distribution and function of tetraspanin proteins. | ||||||
Filipin III | 480-49-9 | sc-205323 sc-205323A | 500 µg 1 mg | $118.00 $148.00 | 26 | |
A polyene macrolide that binds to cholesterol, potentially disrupting lipid rafts and affecting the function of tetraspanin proteins like TM4SF4. | ||||||
25-Hydroxycholesterol | 2140-46-7 | sc-214091B sc-214091 sc-214091A sc-214091C | 5 mg 10 mg 25 mg 100 mg | $53.00 $91.00 $169.00 $474.00 | 8 | |
A fluorescent cholesterol analogue used to study cholesterol distribution that could perturb lipid raft integrity and influence tetraspanin function. | ||||||
U 18666A | 3039-71-2 | sc-203306 sc-203306A | 10 mg 50 mg | $143.00 $510.00 | 2 | |
A cholesterol transport inhibitor that can induce lipid raft disruption, potentially affecting tetraspanin proteins' localization and function. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
An HMG-CoA reductase inhibitor that reduces cholesterol biosynthesis, which may impact lipid raft-dependent tetraspanin functions. | ||||||